Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
https://www.zacks.com/stock/news/2259547/will-alkermes-alks-proprietary-drugs-aid-amid-competition?cid=CS-ZC-FT-analyst_blog|zer_report_update-2259547
Apr 22, 2024 - Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
0
Airline Stock Roundup: UAL & ALK Report Q1 Loss, SAVE Tweaks View
https://www.zacks.com/stock/news/2258387/airline-stock-roundup-ual-alk-report-q1-loss-save-tweaks-view?cid=CS-ZC-FT-analyst_blog|stock_roundup-2258387
Apr 19, 2024 - United Airlines' (UAL) Q1 results benefit from strong air travel demand. Allegiant Travel's (ALGT) flight attendants become eligible for a huge pay raise.
0
Alaska Air Group (ALK) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/04/18/alaska-air-group-alk-q1-2024-earnings-call-transcr/?source=iedfolrf0000001
Apr 18, 2024 - ALK earnings call for the period ending March 31, 2024.
0
FDA approves Roche's Alecensa for early stage ALK+ lung cancer
https://seekingalpha.com/news/4091312-fda-approves-roches-alecensa-for-early-stage-alk-lung-cancer?source=feed_sector_healthcare
Apr 18, 2024 - The FDA has approved Roche’s (RHHBY) Alecensa for the treatment of early stage resected non-small stage lung cancer with ALK+ mutations. Read more here.
0
Alaska Air Group, Inc. (ALK) Q1 2024 Earnings Call Transcript
https://seekingalpha.com/article/4684595-alaska-air-group-inc-alk-q1-2024-earnings-call-transcript?source=feed_sector_transcripts
Apr 18, 2024 - Alaska Air Group, Inc. (NYSE:NYSE:ALK) Q1 2024 Earnings Conference Call April 18, 2024 11:30 AM ETCompany ParticipantsRyan St.
0
Alaska Air (ALK) Incurs Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2257887/alaska-air-alk-incurs-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2257887
Apr 18, 2024 - Alaska Air's (ALK) first-quarter 2024 revenues benefit from contributions from passenger revenues.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2256019/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2256019
Apr 16, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
What's in the Cards for Alaska Air (ALK) in Q1 Earnings?
https://www.zacks.com/stock/news/2254610/what-s-in-the-cards-for-alaska-air-alk-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254610
Apr 12, 2024 - Alaska Air's (ALK) bottom line is under pressure from increasing fuel costs, which is likely to impact its upcoming first-quarter earnings results.
0
Alkermes' (ALKS) ALKS 2680 Betters Wakefulness in Phase Ib Study
https://www.zacks.com/stock/news/2254013/alkermes-alks-alks-2680-betters-wakefulness-in-phase-ib-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254013
Apr 11, 2024 - Alkermes (ALKS) reports positive top-line data from a phase Ib, proof-of-concept study investigating ALKS 2680 for the treatment of narcolepsy.
0
Earnings Preview: Alaska Air Group (ALK) Q1 Earnings Expected to Decline
https://www.zacks.com/stock/news/2253985/earnings-preview-alaska-air-group-alk-q1-earnings-expected-to-decline?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2253985
Apr 11, 2024 - Alaska Air (ALK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Page 1>